[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Brain Tumor Diagnosis and Therapeutics Market Growth (Status and Outlook) 2020-2025

December 2020 | 134 pages | ID: B0DA351F2E8EEN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

According to this study, over the next five years the Brain Tumor Diagnosis and Therapeutics market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Brain Tumor Diagnosis and Therapeutics business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Brain Tumor Diagnosis and Therapeutics market by product type, application, key manufacturers and key regions and countries.

This study specially analyses the impact of Covid-19 outbreak on the Brain Tumor Diagnosis and Therapeutics, covering the supply chain analysis, impact assessment to the Brain Tumor Diagnosis and Therapeutics market size growth rate in several scenarios, and the measures to be undertaken by Brain Tumor Diagnosis and Therapeutics companies in response to the COVID-19 epidemic.

Segmentation by type: breakdown data from 2015 to 2020 in Section 2.3; and forecast to 2025 in section 10.7.
  • MRI
  • CT Scan
  • Tissue Sampling
  • PET-CT Scan
  • Cerebral Arteriogram
  • Lumbar Puncture
  • Molecular Testing
  • EEG
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2025 in section 10.8.
  • Surgery
  • Radiation Therapy
  • Chemotherapy
  • Immunotherapy
  • Targeted Therapy
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
  • GE Healthcare
  • Bristol Myer Squibb
  • Hitachi
  • Siemens Healthineers
  • Toshiba Corporation
  • Philips Healthcare
  • Merck & Co.
  • Fujifilm Corporation
  • AstraZeneca
  • Shimadzu Corporation
  • Novartis
  • Roche Diagnostics
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
  • To study and analyze the global Brain Tumor Diagnosis and Therapeutics market size by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
  • To understand the structure of Brain Tumor Diagnosis and Therapeutics market by identifying its various subsegments.
  • Focuses on the key global Brain Tumor Diagnosis and Therapeutics players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
  • To analyze the Brain Tumor Diagnosis and Therapeutics with respect to individual growth trends, future prospects, and their contribution to the total market.
  • To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
  • To project the size of Brain Tumor Diagnosis and Therapeutics submarkets, with respect to key regions (along with their respective key countries).
  • To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
  • To strategically profile the key players and comprehensively analyze their growth strategies.
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Brain Tumor Diagnosis and Therapeutics Market Size 2015-2025
  2.1.2 Brain Tumor Diagnosis and Therapeutics Market Size CAGR by Region
2.2 Brain Tumor Diagnosis and Therapeutics Segment by Type
  2.2.1 MRI
  2.2.2 MRI
  2.2.3 Tissue Sampling
  2.2.4 PET-CT Scan
  2.2.5 Cerebral Arteriogram
  2.2.6 Lumbar Puncture
  2.2.7 Molecular Testing
  2.2.8 EEG
2.3 Brain Tumor Diagnosis and Therapeutics Market Size by Type
  2.3.1 Global Brain Tumor Diagnosis and Therapeutics Market Size Market Share by Type (2015-2020)
  2.3.2 Global Brain Tumor Diagnosis and Therapeutics Market Size Growth Rate by Type (2015-2020)
2.4 Brain Tumor Diagnosis and Therapeutics Segment by Application
  2.4.1 Surgery
  2.4.2 Radiation Therapy
  2.4.3 Chemotherapy
  2.4.4 Immunotherapy
  2.4.5 Targeted Therapy
2.5 Brain Tumor Diagnosis and Therapeutics Market Size by Application
  2.5.1 Global Brain Tumor Diagnosis and Therapeutics Market Size Market Share by Application (2015-2020)
  2.5.2 Global Brain Tumor Diagnosis and Therapeutics Market Size Growth Rate by Application (2015-2020)

3 GLOBAL BRAIN TUMOR DIAGNOSIS AND THERAPEUTICS BY PLAYERS

3.1 Global Brain Tumor Diagnosis and Therapeutics Market Size Market Share by Players
  3.1.1 Global Brain Tumor Diagnosis and Therapeutics Market Size by Players (2018-2020)
  3.1.2 Global Brain Tumor Diagnosis and Therapeutics Market Size Market Share by Players (2018-2020)
3.2 Global Brain Tumor Diagnosis and Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 BRAIN TUMOR DIAGNOSIS AND THERAPEUTICS BY REGIONS

4.1 Brain Tumor Diagnosis and Therapeutics Market Size by Regions
4.2 Americas Brain Tumor Diagnosis and Therapeutics Market Size Growth
4.3 APAC Brain Tumor Diagnosis and Therapeutics Market Size Growth
4.4 Europe Brain Tumor Diagnosis and Therapeutics Market Size Growth
4.5 Middle East & Africa Brain Tumor Diagnosis and Therapeutics Market Size Growth

5 AMERICAS

5.1 Americas Brain Tumor Diagnosis and Therapeutics Market Size by Countries
5.2 Americas Brain Tumor Diagnosis and Therapeutics Market Size by Type
5.3 Americas Brain Tumor Diagnosis and Therapeutics Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Brain Tumor Diagnosis and Therapeutics Market Size by Regions
6.2 APAC Brain Tumor Diagnosis and Therapeutics Market Size by Type
6.3 APAC Brain Tumor Diagnosis and Therapeutics Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions

7 EUROPE

7.1 Europe Brain Tumor Diagnosis and Therapeutics by Countries
7.2 Europe Brain Tumor Diagnosis and Therapeutics Market Size by Type
7.3 Europe Brain Tumor Diagnosis and Therapeutics Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Brain Tumor Diagnosis and Therapeutics by Countries
8.2 Middle East & Africa Brain Tumor Diagnosis and Therapeutics Market Size by Type
8.3 Middle East & Africa Brain Tumor Diagnosis and Therapeutics Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers and Impact
  9.1.1 Growing Demand from Key Regions
  9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 GLOBAL BRAIN TUMOR DIAGNOSIS AND THERAPEUTICS MARKET FORECAST

10.1 Global Brain Tumor Diagnosis and Therapeutics Market Size Forecast (2021-2025)
10.2 Global Brain Tumor Diagnosis and Therapeutics Forecast by Regions
  10.2.1 Global Brain Tumor Diagnosis and Therapeutics Forecast by Regions (2021-2025)
  10.2.2 Americas Market Forecast
  10.2.3 APAC Market Forecast
  10.2.4 Europe Market Forecast
  10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
  10.3.1 United States Market Forecast
  10.3.2 Canada Market Forecast
  10.3.3 Mexico Market Forecast
  10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
  10.4.1 China Market Forecast
  10.4.2 Japan Market Forecast
  10.4.3 Korea Market Forecast
  10.4.4 Southeast Asia Market Forecast
  10.4.5 India Market Forecast
  10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
  10.5.1 Germany Market Forecast
  10.5.2 France Market Forecast
  10.5.3 UK Market Forecast
  10.5.4 Italy Market Forecast
  10.5.5 Russia Market Forecast
  10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
  10.6.1 Egypt Market Forecast
  10.6.2 South Africa Market Forecast
  10.6.3 Israel Market Forecast
  10.6.4 Turkey Market Forecast
  10.6.5 GCC Countries Market Forecast
10.7 Global Brain Tumor Diagnosis and Therapeutics Forecast by Type
10.8 Global Brain Tumor Diagnosis and Therapeutics Forecast by Application

11 KEY PLAYERS ANALYSIS

11.1 GE Healthcare
  11.1.1 Company Details
  11.1.2 Brain Tumor Diagnosis and Therapeutics Product Offered
  11.1.3 GE Healthcare Brain Tumor Diagnosis and Therapeutics Revenue, Gross Margin and Market Share (2018-2020)
  11.1.4 Main Business Overview
  11.1.5 GE Healthcare News
11.2 Bristol Myer Squibb
  11.2.1 Company Details
  11.2.2 Brain Tumor Diagnosis and Therapeutics Product Offered
  11.2.3 Bristol Myer Squibb Brain Tumor Diagnosis and Therapeutics Revenue, Gross Margin and Market Share (2018-2020)
  11.2.4 Main Business Overview
  11.2.5 Bristol Myer Squibb News
11.3 Hitachi
  11.3.1 Company Details
  11.3.2 Brain Tumor Diagnosis and Therapeutics Product Offered
  11.3.3 Hitachi Brain Tumor Diagnosis and Therapeutics Revenue, Gross Margin and Market Share (2018-2020)
  11.3.4 Main Business Overview
  11.3.5 Hitachi News
11.4 Siemens Healthineers
  11.4.1 Company Details
  11.4.2 Brain Tumor Diagnosis and Therapeutics Product Offered
  11.4.3 Siemens Healthineers Brain Tumor Diagnosis and Therapeutics Revenue, Gross Margin and Market Share (2018-2020)
  11.4.4 Main Business Overview
  11.4.5 Siemens Healthineers News
11.5 Toshiba Corporation
  11.5.1 Company Details
  11.5.2 Brain Tumor Diagnosis and Therapeutics Product Offered
  11.5.3 Toshiba Corporation Brain Tumor Diagnosis and Therapeutics Revenue, Gross Margin and Market Share (2018-2020)
  11.5.4 Main Business Overview
  11.5.5 Toshiba Corporation News
11.6 Philips Healthcare
  11.6.1 Company Details
  11.6.2 Brain Tumor Diagnosis and Therapeutics Product Offered
  11.6.3 Philips Healthcare Brain Tumor Diagnosis and Therapeutics Revenue, Gross Margin and Market Share (2018-2020)
  11.6.4 Main Business Overview
  11.6.5 Philips Healthcare News
11.7 Merck & Co.
  11.7.1 Company Details
  11.7.2 Brain Tumor Diagnosis and Therapeutics Product Offered
  11.7.3 Merck & Co. Brain Tumor Diagnosis and Therapeutics Revenue, Gross Margin and Market Share (2018-2020)
  11.7.4 Main Business Overview
  11.7.5 Merck & Co. News
11.8 Fujifilm Corporation
  11.8.1 Company Details
  11.8.2 Brain Tumor Diagnosis and Therapeutics Product Offered
  11.8.3 Fujifilm Corporation Brain Tumor Diagnosis and Therapeutics Revenue, Gross Margin and Market Share (2018-2020)
  11.8.4 Main Business Overview
  11.8.5 Fujifilm Corporation News
11.9 AstraZeneca
  11.9.1 Company Details
  11.9.2 Brain Tumor Diagnosis and Therapeutics Product Offered
  11.9.3 AstraZeneca Brain Tumor Diagnosis and Therapeutics Revenue, Gross Margin and Market Share (2018-2020)
  11.9.4 Main Business Overview
  11.9.5 AstraZeneca News
11.10 Shimadzu Corporation
  11.10.1 Company Details
  11.10.2 Brain Tumor Diagnosis and Therapeutics Product Offered
  11.10.3 Shimadzu Corporation Brain Tumor Diagnosis and Therapeutics Revenue, Gross Margin and Market Share (2018-2020)
  11.10.4 Main Business Overview
  11.10.5 Shimadzu Corporation News
11.11 Novartis
11.12 Roche Diagnostics

12 RESEARCH FINDINGS AND CONCLUSION


LIST OF TABLES

Table 1. Research Methodology
Table 2. Data Source
Table 3. Brain Tumor Diagnosis and Therapeutics Market Size CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of MRI
Table 5. Major Players of CT Scan
Table 6. Major Players of Tissue Sampling
Table 7. Major Players of PET-CT Scan
Table 8. Major Players of Cerebral Arteriogram
Table 9. Major Players of Lumbar Puncture
Table 10. Major Players of Molecular Testing
Table 11. Major Players of EEG
Table 12. Brain Tumor Diagnosis and Therapeutics Market Size by Type (2014-2019) ($ Millions)
Table 13. Global Brain Tumor Diagnosis and Therapeutics Market Size Market Share by Type (2015-2020)
Table 14. Global Brain Tumor Diagnosis and Therapeutics Market Size by Application (2015-2020) ($ Millions)
Table 15. Global Brain Tumor Diagnosis and Therapeutics Market Size Market Share by Application (2015-2020)
Table 16. Global Brain Tumor Diagnosis and Therapeutics Revenue by Players (2018-2020) ($ Millions)
Table 17. Global Brain Tumor Diagnosis and Therapeutics Revenue Market Share by Players (2018-2020)
Table 18. Global Brain Tumor Diagnosis and Therapeutics Key Players Head office and Products Offered
Table 19. Brain Tumor Diagnosis and Therapeutics Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
Table 20. New Products and Potential Entrants
Table 21. Mergers & Acquisitions, Expansion
Table 22. Global Brain Tumor Diagnosis and Therapeutics Market Size by Regions 2015-2020 ($ Millions)
Table 23. Global Brain Tumor Diagnosis and Therapeutics Market Size Market Share by Regions 2015-2020
Table 24. Americas Brain Tumor Diagnosis and Therapeutics Market Size by Countries (2015-2020) ($ Millions)
Table 25. Americas Brain Tumor Diagnosis and Therapeutics Market Size Market Share by Countries (2015-2020)
Table 26. Americas Brain Tumor Diagnosis and Therapeutics Market Size by Type (2015-2020) ($ Millions)
Table 27. Americas Brain Tumor Diagnosis and Therapeutics Market Size Market Share by Type (2015-2020)
Table 28. Americas Brain Tumor Diagnosis and Therapeutics Market Size by Application (2015-2020) ($ Millions)
Table 29. Americas Brain Tumor Diagnosis and Therapeutics Market Size Market Share by Application (2015-2020)
Table 30. APAC Brain Tumor Diagnosis and Therapeutics Market Size by Regions (2015-2020) ($ Millions)
Table 31. APAC Brain Tumor Diagnosis and Therapeutics Market Size Market Share by Regions (2015-2020)
Table 32. APAC Brain Tumor Diagnosis and Therapeutics Market Size by Type (2015-2020) ($ Millions)
Table 33. APAC Brain Tumor Diagnosis and Therapeutics Market Size Market Share by Type (2015-2020)
Table 34. APAC Brain Tumor Diagnosis and Therapeutics Market Size by Application (2015-2020) ($ Millions)
Table 35. APAC Brain Tumor Diagnosis and Therapeutics Market Size Market Share by Application (2015-2020)
Table 36. Europe Brain Tumor Diagnosis and Therapeutics Market Size by Countries (2015-2020) ($ Millions)
Table 37. Europe Brain Tumor Diagnosis and Therapeutics Market Size Market Share by Countries (2015-2020)
Table 38. Europe Brain Tumor Diagnosis and Therapeutics Market Size by Type (2015-2020) ($ Millions)
Table 39. Europe Brain Tumor Diagnosis and Therapeutics Market Size Market Share by Type (2015-2020)
Table 40. Europe Brain Tumor Diagnosis and Therapeutics Market Size by Application (2015-2020) ($ Millions)
Table 41. Europe Brain Tumor Diagnosis and Therapeutics Market Size Market Share by Application (2015-2020)
Table 42. Middle East & Africa Brain Tumor Diagnosis and Therapeutics Market Size by Countries (2015-2020) ($ Millions)
Table 43. Middle East & Africa Brain Tumor Diagnosis and Therapeutics Market Size Market Share by Countries (2015-2020)
Table 44. Middle East & Africa Brain Tumor Diagnosis and Therapeutics Market Size by Type (2015-2020) ($ Millions)
Table 45. Middle East & Africa Brain Tumor Diagnosis and Therapeutics Market Size Market Share by Type (2015-2020)
Table 46. Middle East & Africa Brain Tumor Diagnosis and Therapeutics Market Size by Application (2015-2020) ($ Millions)
Table 47. Middle East & Africa Brain Tumor Diagnosis and Therapeutics Market Size Market Share by Application (2015-2020)
Table 48. Key and Potential Regions of Brain Tumor Diagnosis and Therapeutics
Table 49. Key Application and Potential Industries of Brain Tumor Diagnosis and Therapeutics
Table 50. Key Challenges of Brain Tumor Diagnosis and Therapeutics
Table 51. Key Trends of Brain Tumor Diagnosis and Therapeutics
Table 52. Global Brain Tumor Diagnosis and Therapeutics Market Size Forecast by Regions (2021-2025) ($ Millions)
Table 53. Global Brain Tumor Diagnosis and Therapeutics Market Size Market Share Forecast by Regions
Table 54. Global Brain Tumor Diagnosis and Therapeutics Market Size Forecast by Type (2021-2025) ($ Millions)
Table 55. Global Brain Tumor Diagnosis and Therapeutics Market Size Market Share Forecast by Type (2021-2025)
Table 56. Global Brain Tumor Diagnosis and Therapeutics Market Size Forecast by Application (2021-2025) ($ Millions)
Table 57. Global Brain Tumor Diagnosis and Therapeutics Market Size Market Share Forecast by Application (2021-2025)
Table 58. GE Healthcare Details, Company Total Revenue (in $ million), Head Office, Brain Tumor Diagnosis and Therapeutics Major Market Areas and Its Competitors
Table 59. GE Healthcare Brain Tumor Diagnosis and Therapeutics Product Offered
Table 60. GE Healthcare Brain Tumor Diagnosis and Therapeutics Revenue and Gross Margin (2018-2020E)
Table 61. GE Healthcare Main Business
Table 62. GE Healthcare Latest Developments
Table 63. Bristol Myer Squibb Details, Company Total Revenue (in $ million), Head Office, Brain Tumor Diagnosis and Therapeutics Major Market Areas and Its Competitors
Table 64. Bristol Myer Squibb Brain Tumor Diagnosis and Therapeutics Product Offered
Table 65. Bristol Myer Squibb Main Business
Table 66. Bristol Myer Squibb Brain Tumor Diagnosis and Therapeutics Revenue and Gross Margin (2018-2020E)
Table 67. Bristol Myer Squibb Latest Developments
Table 68. Hitachi Details, Company Total Revenue (in $ million), Head Office, Brain Tumor Diagnosis and Therapeutics Major Market Areas and Its Competitors
Table 69. Hitachi Brain Tumor Diagnosis and Therapeutics Product Offered
Table 70. Hitachi Main Business
Table 71. Hitachi Brain Tumor Diagnosis and Therapeutics Revenue and Gross Margin (2018-2020E)
Table 72. Hitachi Latest Developments
Table 73. Siemens Healthineers Details, Company Total Revenue (in $ million), Head Office, Brain Tumor Diagnosis and Therapeutics Major Market Areas and Its Competitors
Table 74. Siemens Healthineers Brain Tumor Diagnosis and Therapeutics Product Offered
Table 75. Siemens Healthineers Main Business
Table 76. Siemens Healthineers Brain Tumor Diagnosis and Therapeutics Revenue and Gross Margin (2018-2020E)
Table 77. Siemens Healthineers Latest Developments
Table 78. Toshiba Corporation Details, Company Total Revenue (in $ million), Head Office, Brain Tumor Diagnosis and Therapeutics Major Market Areas and Its Competitors
Table 79. Toshiba Corporation Brain Tumor Diagnosis and Therapeutics Product Offered
Table 80. Toshiba Corporation Main Business
Table 81. Toshiba Corporation Brain Tumor Diagnosis and Therapeutics Revenue and Gross Margin (2018-2020E)
Table 82. Toshiba Corporation Latest Developments
Table 83. Philips Healthcare Details, Company Total Revenue (in $ million), Head Office, Brain Tumor Diagnosis and Therapeutics Major Market Areas and Its Competitors
Table 84. Philips Healthcare Brain Tumor Diagnosis and Therapeutics Product Offered
Table 85. Philips Healthcare Main Business
Table 86. Philips Healthcare Brain Tumor Diagnosis and Therapeutics Revenue and Gross Margin (2018-2020E)
Table 87. Philips Healthcare Latest Developments
Table 88. Merck & Co. Details, Company Total Revenue (in $ million), Head Office, Brain Tumor Diagnosis and Therapeutics Major Market Areas and Its Competitors
Table 89. Merck & Co. Brain Tumor Diagnosis and Therapeutics Product Offered
Table 90. Merck & Co. Main Business
Table 91. Merck & Co. Brain Tumor Diagnosis and Therapeutics Revenue and Gross Margin (2018-2020E)
Table 92. Merck & Co. Latest Developments
Table 93. Fujifilm Corporation Details, Company Total Revenue (in $ million), Head Office, Brain Tumor Diagnosis and Therapeutics Major Market Areas and Its Competitors
Table 94. Fujifilm Corporation Brain Tumor Diagnosis and Therapeutics Product Offered
Table 95. Fujifilm Corporation Main Business
Table 96. Fujifilm Corporation Brain Tumor Diagnosis and Therapeutics Revenue and Gross Margin (2018-2020E)
Table 97. Fujifilm Corporation Latest Developments
Table 98. AstraZeneca Details, Company Total Revenue (in $ million), Head Office, Brain Tumor Diagnosis and Therapeutics Major Market Areas and Its Competitors
Table 99. AstraZeneca Brain Tumor Diagnosis and Therapeutics Product Offered
Table 100. AstraZeneca Main Business
Table 101. AstraZeneca Brain Tumor Diagnosis and Therapeutics Revenue and Gross Margin (2018-2020E)
Table 102. AstraZeneca Latest Developments
Table 103. Shimadzu Corporation Details, Company Total Revenue (in $ million), Head Office, Brain Tumor Diagnosis and Therapeutics Major Market Areas and Its Competitors
Table 104. Shimadzu Corporation Brain Tumor Diagnosis and Therapeutics Product Offered
Table 105. Shimadzu Corporation Main Business
Table 106. Shimadzu Corporation Brain Tumor Diagnosis and Therapeutics Revenue and Gross Margin (2018-2020E)
Table 107. Shimadzu Corporation Latest Developments
Table 108. Novartis Details, Company Total Revenue (in $ million), Head Office, Brain Tumor Diagnosis and Therapeutics Major Market Areas and Its Competitors
Table 109. Roche Diagnostics Details, Company Total Revenue (in $ million), Head Office, Brain Tumor Diagnosis and Therapeutics Major Market Areas and Its Competitors

LIST OF FIGURES

Figure 1. Brain Tumor Diagnosis and Therapeutics Report Years Considered
Figure 2. Market Research Methodology
Figure 3. Global Brain Tumor Diagnosis and Therapeutics Market Size Growth Rate 2015-2025 ($ Millions)
Figure 4. Global Brain Tumor Diagnosis and Therapeutics Market Size Market Share by Type (2015-2020)
Figure 5. Global MRI Market Size Growth Rate
Figure 6. Global CT Scan Market Size Growth Rate
Figure 7. Global Tissue Sampling Market Size Growth Rate
Figure 8. Global PET-CT Scan Market Size Growth Rate
Figure 9. Global Cerebral Arteriogram Market Size Growth Rate
Figure 10. Global Lumbar Puncture Market Size Growth Rate
Figure 11. Global Molecular Testing Market Size Growth Rate
Figure 12. Global EEG Market Size Growth Rate
Figure 13. Brain Tumor Diagnosis and Therapeutics in Surgery
Figure 14. Global Brain Tumor Diagnosis and Therapeutics Market: Surgery (2015-2020) ($ Millions)
Figure 15. Brain Tumor Diagnosis and Therapeutics in Radiation Therapy
Figure 16. Global Brain Tumor Diagnosis and Therapeutics Market: Radiation Therapy (2015-2020) ($ Millions)
Figure 17. Brain Tumor Diagnosis and Therapeutics in Chemotherapy
Figure 18. Global Brain Tumor Diagnosis and Therapeutics Market: Chemotherapy (2015-2020) ($ Millions)
Figure 19. Global Chemotherapy YoY Growth ($ Millions)
Figure 20. Brain Tumor Diagnosis and Therapeutics in Immunotherapy
Figure 21. Global Brain Tumor Diagnosis and Therapeutics Market: Immunotherapy (2015-2020) ($ Millions)
Figure 22. Global Immunotherapy YoY Growth ($ Millions)
Figure 23. Brain Tumor Diagnosis and Therapeutics in Targeted Therapy
Figure 24. Global Brain Tumor Diagnosis and Therapeutics Market: Targeted Therapy (2015-2020) ($ Millions)
Figure 25. Global Targeted Therapy YoY Growth ($ Millions)
Figure 26. Global Brain Tumor Diagnosis and Therapeutics Market Size Market Share by Application in 2019
Figure 27. Global Brain Tumor Diagnosis and Therapeutics Market Size Market Share by Regions 2015-2020
Figure 28. Americas Brain Tumor Diagnosis and Therapeutics Market Size 2015-2020 ($ Millions)
Figure 29. APAC Brain Tumor Diagnosis and Therapeutics Market Size 2015-2020 ($ Millions)
Figure 30. Europe Brain Tumor Diagnosis and Therapeutics Market Size 2015-2020 ($ Millions)
Figure 31. Middle East & Africa Brain Tumor Diagnosis and Therapeutics Market Size 2015-2020 ($ Millions)
Figure 32. Americas Brain Tumor Diagnosis and Therapeutics Market Size Market Share by Countries in 2019
Figure 33. Americas Brain Tumor Diagnosis and Therapeutics Market Size Market Share by Type in 2019
Figure 34. Americas Brain Tumor Diagnosis and Therapeutics Market Size Market Share by Application in 2019
Figure 35. United States Brain Tumor Diagnosis and Therapeutics Market Size Growth 2015-2020 ($ Millions)
Figure 36. Canada Brain Tumor Diagnosis and Therapeutics Market Size Growth 2015-2020 ($ Millions)
Figure 37. Mexico Brain Tumor Diagnosis and Therapeutics Market Size Growth 2015-2020 ($ Millions)
Figure 38. APAC Brain Tumor Diagnosis and Therapeutics Market Size Market Share by Regions in 2019
Figure 39. APAC Brain Tumor Diagnosis and Therapeutics Market Size Market Share by Type in 2019
Figure 40. APAC Brain Tumor Diagnosis and Therapeutics Market Size Market Share by Application in 2019
Figure 41. China Brain Tumor Diagnosis and Therapeutics Market Size Growth 2015-2020 ($ Millions)
Figure 42. Japan Brain Tumor Diagnosis and Therapeutics Market Size Growth 2015-2020 ($ Millions)
Figure 43. Korea Brain Tumor Diagnosis and Therapeutics Market Size Growth 2015-2020 ($ Millions)
Figure 44. Southeast Asia Brain Tumor Diagnosis and Therapeutics Market Size Growth 2015-2020 ($ Millions)
Figure 45. India Brain Tumor Diagnosis and Therapeutics Market Size Growth 2015-2020 ($ Millions)
Figure 46. Australia Brain Tumor Diagnosis and Therapeutics Market Size Growth 2015-2020 ($ Millions)
Figure 47. Europe Brain Tumor Diagnosis and Therapeutics Market Size Market Share by Countries in 2019
Figure 48. Europe Brain Tumor Diagnosis and Therapeutics Market Size Market Share by Type in 2019
Figure 49. Europe Brain Tumor Diagnosis and Therapeutics Market Size Market Share by Application in 2019
Figure 50. Germany Brain Tumor Diagnosis and Therapeutics Market Size Growth 2015-2020 ($ Millions)
Figure 51. France Brain Tumor Diagnosis and Therapeutics Market Size Growth 2015-2020 ($ Millions)
Figure 52. UK Brain Tumor Diagnosis and Therapeutics Market Size Growth 2015-2020 ($ Millions)
Figure 53. Italy Brain Tumor Diagnosis and Therapeutics Market Size Growth 2015-2020 ($ Millions)
Figure 54. Russia Brain Tumor Diagnosis and Therapeutics Market Size Growth 2015-2020 ($ Millions)
Figure 55. Spain Brain Tumor Diagnosis and Therapeutics Market Size Growth 2015-2020 ($ Millions)
Figure 56. Middle East & Africa Brain Tumor Diagnosis and Therapeutics Market Size Market Share by Countries in 2019
Figure 57. Middle East & Africa Brain Tumor Diagnosis and Therapeutics Market Size Market Share by Type in 2019
Figure 58. Middle East & Africa Brain Tumor Diagnosis and Therapeutics Market Size Market Share by Application in 2019
Figure 59. Egypt Brain Tumor Diagnosis and Therapeutics Market Size Growth 2015-2020 ($ Millions)
Figure 60. South Africa Brain Tumor Diagnosis and Therapeutics Market Size Growth 2015-2020 ($ Millions)
Figure 61. Israel Brain Tumor Diagnosis and Therapeutics Market Size Growth 2015-2020 ($ Millions)
Figure 62. Turkey Brain Tumor Diagnosis and Therapeutics Market Size Growth 2015-2020 ($ Millions)
Figure 63. GCC Countries Brain Tumor Diagnosis and Therapeutics Market Size Growth 2015-2020 ($ Millions)
Figure 64. Global Brain Tumor Diagnosis and Therapeutics arket Size Forecast (2021-2025) ($ Millions)
Figure 65. Americas Brain Tumor Diagnosis and Therapeutics Market Size 2021-2025 ($ Millions)
Figure 66. APAC Brain Tumor Diagnosis and Therapeutics Market Size 2021-2025 ($ Millions)
Figure 67. Europe Brain Tumor Diagnosis and Therapeutics Market Size 2021-2025 ($ Millions)
Figure 68. Middle East & Africa Brain Tumor Diagnosis and Therapeutics Market Size 2021-2025 ($ Millions)
Figure 69. United States Brain Tumor Diagnosis and Therapeutics Market Size 2021-2025 ($ Millions)
Figure 70. Canada Brain Tumor Diagnosis and Therapeutics Market Size 2021-2025 ($ Millions)
Figure 71. Mexico Brain Tumor Diagnosis and Therapeutics Market Size 2021-2025 ($ Millions)
Figure 72. Brazil Brain Tumor Diagnosis and Therapeutics Market Size 2021-2025 ($ Millions)
Figure 73. China Brain Tumor Diagnosis and Therapeutics Market Size 2021-2025 ($ Millions)
Figure 74. Japan Brain Tumor Diagnosis and Therapeutics Market Size 2021-2025 ($ Millions)
Figure 75. Korea Brain Tumor Diagnosis and Therapeutics Market Size 2021-2025 ($ Millions)
Figure 76. Southeast Asia Brain Tumor Diagnosis and Therapeutics Market Size 2021-2025 ($ Millions)
Figure 77. India Brain Tumor Diagnosis and Therapeutics Market Size 2021-2025 ($ Millions)
Figure 78. Australia Brain Tumor Diagnosis and Therapeutics Market Size 2021-2025 ($ Millions)
Figure 79. Germany Brain Tumor Diagnosis and Therapeutics Market Size 2021-2025 ($ Millions)
Figure 80. France Brain Tumor Diagnosis and Therapeutics Market Size 2021-2025 ($ Millions)
Figure 81. UK Brain Tumor Diagnosis and Therapeutics Market Size 2021-2025 ($ Millions)
Figure 82. Italy Brain Tumor Diagnosis and Therapeutics Market Size 2021-2025 ($ Millions)
Figure 83. Russia Brain Tumor Diagnosis and Therapeutics Market Size 2021-2025 ($ Millions)
Figure 84. Spain Brain Tumor Diagnosis and Therapeutics Market Size 2021-2025 ($ Millions)
Figure 85. Egypt Brain Tumor Diagnosis and Therapeutics Market Size 2021-2025 ($ Millions)
Figure 86. South Africa Brain Tumor Diagnosis and Therapeutics Market Size 2021-2025 ($ Millions)
Figure 87. Israel Brain Tumor Diagnosis and Therapeutics Market Size 2021-2025 ($ Millions)
Figure 88. Turkey Brain Tumor Diagnosis and Therapeutics Market Size 2021-2025 ($ Millions)
Figure 89. GCC Countries Brain Tumor Diagnosis and Therapeutics Market Size 2021-2025 ($ Millions)


More Publications